Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma
Roche today announced that new data on its investigational CD20xCD3 T-cell engaging bispecific antibodies, mosunetuzumab and ...
Read more
Tag: roche
European Commission approves Venclyxto-based combinations for acute myeloid leukaemia
Roche announced that the European Commission has approved Venclyxto® (venetoclax) in combination for the treatment of ...
Read more
Roche’s Tecentriq approved in EU as a first-line monotherapy treatment for metastatic non-small cell lung cancer
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in a Phase ...
Read more
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail for treatment of Covid-19
Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients ...
Read more
US FDA Advisory Committee votes in favour of Roche’s Tecentriq
Roche announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted ...
Read moreRoche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)
More than twice as many babies (61% vs. 29%) were able to sit without support for ...
Read more
Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types
Anti-p53 antibodies are antibodies that mistakenly target a patient's own tissues, leading to a growth of ...
Read moreRoche launches Elecsys Epstein-Barr Virus (EBV) immunoassay panel to improve EBV infection staging
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which ...
Read more
Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy
Evrysdi has proven efficacy in adults, children and babies two months and older, as shown in ...
Read moreRoche receives positive CHMP opinion for Tecentriq in treatment for people with a type of metastatic non-small cell lung cancer
Recommendation is based on the Phase III IMpower110 study showing that Tecentriq significantly improved overall survival ...
Read more